CFLT vs NPCE · rev $963.6M vs rev $100.0M
Confluent Inc (CFLT) versus Neuropace Inc (NPCE) — a side-by-side from cached financials, not a winner call.
Confluent Inc (CFLT) is a software - infrastructure company listed on US.
Neuropace Inc (NPCE) is a medical devices company listed on US.
Latest reported CFLT revenue for 2024-12-31 was $963.6M. Net income was -$345.1M. Revenue was up 24.0% from 2023-12-31 to 2024-12-31. CFLT currently screens at market cap $11.13B.
Latest reported NPCE revenue for 2025-12-31 was $100.0M. Net income was -$21.5M. Revenue was up 25.1% from 2024-12-31 to 2025-12-31. NPCE currently screens at market cap $312.2M.
CFLT currently screens at market cap $11.13B. NPCE currently screens at market cap $312.2M.
Not investment advice. Open the CFLT and NPCE stock pages for the full models.
Not investment advice.